Get started
Work

Abstract 2796: Translating combined PD1 and LAG3 inhibition from preclinical models to patients with refractory, DNA replication repair deficient (RRD) glioblastoma: An IRRDC study

Year: 2026
Type: conference-abstract
DOI: 10.1158/1538-7445.am2026-2796
Authors: Anirban Das, Vienna Mazzoli, Owen Crump, Olha Kos, Nuno M. Nunes, Lucie Stengs, Amanda Li, Adrian Levine, Yoshiko Nakano, Hope Friedman, Katharine O'Flaherty, Alexander Stein, Gadi Abebe-Campino, Annika Bronsema, Vanessa Bianchi, Melissa Edwards, Stergios Zacharoulis, Birgit Ertl-Wagner, Daniel A. Morgenstern, Trevor J. Pugh, Pamela Ohashi, Eric Bouffet, Cynthia E. Hawkins, Peter B. Dirks, Uri Y. Tabori
Institutions: Hospital for Sick Children, University Medical Center Hamburg-Eppendorf, Sheba Medical Center, Bristol-Myers Squibb (United States), The Bristol-Myers Squibb Children's Hospital, University Health Network, Princess Margaret Cancer Centre
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148728772
Cites:
Cited by:
Related to: